탈모 시장 규모는 향후 몇 년 동안 안정적인 성장을 보일 것으로 예상되며, 2029년에는 4.6%의 CAGR로 138억 8,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 고령화 인구 증가, 미용에 대한 관심 증가, 라이프스타일 요인 증가, 의료비 지출 증가에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 치료 옵션의 발전, 생명공학 혁신, 인공지능(AI) 및 머신러닝(ML)의 연구 활용 확대 등이 있습니다.
탈모의 유병률 증가가 예상됨에 따라 향후 몇 년 동안 탈모 시장의 성장이 예상됩니다. 탈모는 전형적인 성장 부위에서 모발이 부분적으로 또는 완전히 빠지는 것이 특징이며, 많은 사람들이 앓고 있는 질환입니다. 탈모 치료는 발모 촉진, 맞춤형 치료 전략의 고안, 병용요법의 활용, 탈모의 신체적 증상 관리 등 탈모의 다양한 측면을 다루는 데 있어 중요한 역할을 합니다. 이러한 개입은 개인의 정신적 행복과 전반적인 삶의 질을 크게 향상시킬 수 있습니다. 예를 들어, 2023년 4월 현재 중국 국가위생위원회 데이터에 따르면, 2억 5천만 명 이상의 중국인이 탈모를 경험했으며, 그 중 42%가 26-30세 연령대에 속합니다. 또한 미국 통계 뇌 연구소의 2023년 2월 데이터에 따르면 남성의 약 40%가 35 세까지 눈에 띄는 탈모를 경험하고이 비율은 60 세까지 65%로 증가할 것이라고합니다. 따라서 탈모 유병률의 증가는 탈모 시장 확대의 주요 촉진요인이 되고 있습니다.
정부 이니셔티브의 대폭적인 증가는 탈모 시장의 향후 성장을 촉진할 것입니다. 정부 이니셔티브에는 특정 문제를 해결하거나 특정 목적을 달성하거나 유권자 또는 사회 전체의 전반적인 복지를 향상시키기 위해 다양한 수준의 정부 당국이 시행하는 구체적인 행동, 정책, 프로그램 및 프로젝트가 포함됩니다. 정부 이니셔티브는 연구를 위한 자금 배분, 신약 및 치료법 승인 절차의 신속화, 일반 대중과 의료 전문가를 대상으로 한 캠페인 등 다양한 수단을 통해 탈모 치료의 발전에 크게 기여할 수 있습니다. 한 예로, gov.ie가 보도한 바와 같이, 아일랜드 정부는 2022년 6월 질병으로 인한 탈모로 고통받는 개인을 지원하기 위해 가발, 헤어피스, 기타 대체 모발 구매 비용으로 525.36달러(500유로)의 보조금을 새롭게 도입했습니다. 이러한 이니셔티브는 탈모 및 관련 증상을 가진 사람들의 삶의 질을 크게 향상시킬 수 있습니다. 결과적으로 정부 이니셔티브의 급증은 탈모 시장 성장의 원동력이 되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 탈모 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업 분석
- 세계의 탈모 시장 : 성장률 분석
- 세계의 탈모 시장 실적 : 규모와 성장, 2019-2024
- 세계의 탈모 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 탈모 전체 시장(TAM)
제6장 시장 세분화
- 세계의 탈모 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 탈모 에리아타
- 안드로겐성 탈모
- 탈모 토타리스
- 트랙션 탈모
- 흉터 탈모
- 기타 유형
- 세계의 탈모 시장 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 제약
- 저출력 레이저 치료(LLLT) 장비
- 모발 이식
- 재생의료
- 기타 치료법
- 세계의 탈모 시장성별 : , 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 남
- 여성
- 세계의 탈모 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 기타 유통 채널
- 세계의 탈모 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 피부과 클리닉
- 홈케어 설정
- 기타 최종사용자
- 세계의 탈모 시장, 탈모 Areata 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 패치장 탈모 원형
- 지속적인 반장 탈모 원형
- 탈모 유니바사리스
- 확산 탈모 원형
- 오피아시스
- 세계의 탈모 시장, 남성형 탈모 유형별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 남성형 탈모
- 여성형 탈모
- 세계의 탈모 시장, 탈모 Totalis 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 두피 완전한 탈모
- 세계의 탈모 시장 견인성 탈모 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 프런트 트랙션 탈모
- 후두 견인 탈모
- 세계의 탈모 시장 반흔성 탈모 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 지의류 프라노피라리스
- 원판상 홍반루푸스
- 중심 원심 흉터 탈모
- 이마 섬유화 탈모
- 모낭염 디칼 밴
- 세계의 탈모 시장, 기타 유형 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 휴지기 탈모
- 성장기 탈모
- 탈모
제7장 지역별·국가별 분석
- 세계의 탈모 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 탈모 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 탈모 시장 : 경쟁 구도
- 탈모 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson and Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Sanofi SA
- GlaxoSmithKline Plc
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- Allergan Plc
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company Plc
- Intertek Group Plc
- Dr. Reddy's Laboratories Ltd.
- Cipla Limited
- Almirall S.A.
- Aclaris Therapeutics Inc.
- Curallux LLC
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 탈모 시장 2029 : 새로운 기회를 제공하는 국가
- 탈모 시장 2029 : 새로운 기회를 제공하는 부문
- 탈모 시장 2029 : 성장 전략
제36장 부록
ksm
Alopecia is a medical term describing the loss of hair, which can occur naturally, be associated with illnesses or the use of specific medications. It can manifest as localized or diffuse, temporary or permanent, and affect individuals of all ages and both genders. Treatment for alopecia aims to slow down, reverse, or manage hair loss and encourage regrowth in affected areas.
The primary types of alopecia include alopecia areata, androgenetic alopecia, alopecia totalis, traction alopecia, cicatricial alopecia, and others. Alopecia areata is an autoimmune condition characterized by sudden hair loss resulting in circular or oval patches on the scalp or other body areas. Various treatment options encompass pharmaceuticals, low-level laser therapy devices, hair transplants, regenerative medicine, and more. These treatments are available through diverse distribution channels like hospital pharmacies, retail pharmacies, online pharmacies, and others, catering to a wide range of end-users including dermatology clinics, home care settings, and more.
The alopecia market research report is one of a series of new reports from The Business Research Company that provides alopecia market statistics, including alopecia industry global market size, regional shares, competitors with an alopecia market share, detailed alopecia market segments, market trends and opportunities and any further data you may need to thrive in the alopecia industry. This alopecia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The alopecia market size has grown steadily in recent years. It will grow from $11.05 billion in 2024 to $11.6 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to growing awareness of diagnosis, increasing consumer demand, increasing number of international medical tourism centers, improved reimbursement scenarios.
The alopecia market size is expected to see steady growth in the next few years. It will grow to $13.88 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing aging population, rising cosmetic concerns, increasing lifestyle factors, rising healthcare expenditure. Major trends in the forecast period include advancements in treatment options, biotechnological innovations, the growing use of artificial intelligence (AI) and machine learning (ML) in alopecia research.
The anticipated rise in the prevalence of hair loss is expected to drive the growth of the alopecia market in the coming years. Hair loss, characterized by the partial or complete loss of hair from its typical growth areas, is a condition that affects many individuals. Alopecia treatments play a crucial role in addressing various aspects of hair loss, including promoting hair regrowth, devising personalized treatment strategies, utilizing combination therapies, and managing the physical manifestations of hair loss. These interventions can significantly enhance an individual's emotional well-being and overall quality of life. For example, as of April 2023, data from the China-based National Health Commission indicates that over 250 million Chinese people have experienced hair loss, with 42% of them falling within the age range of 26 to 30. Additionally, data from the US-based Statistic Brain Research Institute in February 2023 reveals that approximately 40% of men will experience noticeable hair loss by the age of 35, and this percentage will increase to 65% by the age of 60. Hence, the growing prevalence of hair loss is a key driver behind the expansion of the alopecia market.
The substantial increase in government initiatives is poised to drive the growth of the alopecia market in the future. Government initiatives encompass specific actions, policies, programs, or projects undertaken by government authorities at various levels to address particular issues, achieve specific objectives, or enhance the overall well-being of their constituents and society as a whole. Government initiatives can significantly contribute to the advancement of alopecia treatment through various means, such as allocating funds for research, expediting the approval process for new drugs and therapies, and launching public awareness campaigns to educate both the public and healthcare professionals about alopecia. As an illustration, in June 2022, the Government of Ireland, as reported by gov.ie, introduced a new grant of $525.36 (€500) to assist individuals experiencing hair loss due to illness in covering the costs of wigs, hairpieces, or other hair replacements. Such initiatives can notably enhance the quality of life for those dealing with alopecia and related conditions. Consequently, the upsurge in government initiatives is a driving force behind the growth of the alopecia market.
Major companies operating in the alopecia market are focused on developing an innovative treatments to gain competitive advantages in the market. For instance, in June 2022, Eli Lilly and Company, a US-based pharmaceutical company and Incyte, a US-based pharmaceutical company, unveiled their approval for is luminant oral tablets by the United States Food and Drug Administration (FDA), a US-based federal agency. It is the first FDA-approved systemic treatment for treating severe alopecia areata in adults. Olumiant is also indicated for treating adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) blockers.
In March 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 million. With this acquisition, Sun Pharmaceutical aims to improve and enhance its alopecia treatment offerings and expand its product portfolio. Concert Pharmaceuticals Inc. is a US-based biopharmaceutical company involved in developing oral inhibitors of Janus kinases as a treatment for alopecia areata.
Major companies operating in the alopecia market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi SA, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Allergan PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Intertek Group PLC, Dr. Reddy's Laboratories Ltd., Cipla Limited, Almirall S.A., Aclaris Therapeutics Inc., Curallux LLC, Theradome Inc., Lexington International LLC, Histogen Inc., Apira Science Inc.
North America was the largest region in the alopecia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The countries covered in the alopecia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The alopecia market consists of revenues earned by entities by providing anagen effluvium, telogen effluvium, and alopecia universalis treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The alopecia market also includes the sales of shampoos, drugs, and hair regrowth supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Alopecia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on alopecia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for alopecia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alopecia market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Alopecia Areata; Androgenetic Alopecia; Alopecia Totalis; Traction Alopecia; Cicatricial Alopecia; Other Types
- 2) By Treatment: Pharmaceutical; Low Level Laser Therapy (LLLT) Devices; Hair Transplant; Regenerative Medicine; Other Treatments
- 3) By Gender: Male; Female
- 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
- 5) By End-User: Dermatology Clinics; Homecare Settings; Other End-Users
- Subsegments:
- 1) By Alopecia Areata: Patchy Alopecia Areata; Persistent Patchy Alopecia Areata; Alopecia Universalis; Diffuse Alopecia Areata; Ophiasis
- 2) By Androgenetic Alopecia: Male Pattern Baldness; Female Pattern Hair Loss
- 3) By Alopecia Totalis: Complete Scalp Hair Loss
- 4) By Traction Alopecia: Frontal Traction Alopecia; Occipital Traction Alopecia
- 5) By Cicatricial Alopecia: Lichen Planopilaris; Discoid Lupus Erythematosus; Central Centrifugal Cicatricial Alopecia; Frontal Fibrosing Alopecia; Folliculitis Decalvans
- 6) By Other Types: Telogen Effluvium; Anagen Effluvium; Trichotillomania
- Companies Mentioned: Pfizer Inc.; Johnson and Johnson Ltd.; Merck and Co. Inc.; Bayer AG; Novartis AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Alopecia Market Characteristics
3. Alopecia Market Trends And Strategies
4. Alopecia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Alopecia Growth Analysis And Strategic Analysis Framework
- 5.1. Global Alopecia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Alopecia Market Growth Rate Analysis
- 5.4. Global Alopecia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Alopecia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Alopecia Total Addressable Market (TAM)
6. Alopecia Market Segmentation
- 6.1. Global Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Alopecia Areata
- Androgenetic Alopecia
- Alopecia Totalis
- Traction Alopecia
- Cicatricial Alopecia
- Other Types
- 6.2. Global Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceutical
- Low Level Laser Therapy (LLLT) Devices
- Hair Transplant
- Regenerative Medicine
- Other Treatments
- 6.3. Global Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Male
- Female
- 6.4. Global Alopecia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- 6.5. Global Alopecia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dermatology Clinics
- Homecare Settings
- Other End-Users
- 6.6. Global Alopecia Market, Sub-Segmentation Of Alopecia Areata, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Patchy Alopecia Areata
- Persistent Patchy Alopecia Areata
- Alopecia Universalis
- Diffuse Alopecia Areata
- Ophiasis
- 6.7. Global Alopecia Market, Sub-Segmentation Of Androgenetic Alopecia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Male Pattern Baldness
- Female Pattern Hair Loss
- 6.8. Global Alopecia Market, Sub-Segmentation Of Alopecia Totalis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Complete Scalp Hair Loss
- 6.9. Global Alopecia Market, Sub-Segmentation Of Traction Alopecia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Frontal Traction Alopecia
- Occipital Traction Alopecia
- 6.10. Global Alopecia Market, Sub-Segmentation Of Cicatricial Alopecia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lichen Planopilaris
- Discoid Lupus Erythematosus
- Central Centrifugal Cicatricial Alopecia
- Frontal Fibrosing Alopecia
- Folliculitis Decalvans
- 6.11. Global Alopecia Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Telogen Effluvium
- Anagen Effluvium
- Trichotillomania
7. Alopecia Market Regional And Country Analysis
- 7.1. Global Alopecia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Alopecia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Alopecia Market
- 8.1. Asia-Pacific Alopecia Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Alopecia Market
- 9.1. China Alopecia Market Overview
- 9.2. China Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Alopecia Market
- 10.1. India Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Alopecia Market
- 11.1. Japan Alopecia Market Overview
- 11.2. Japan Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Alopecia Market
- 12.1. Australia Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Alopecia Market
- 13.1. Indonesia Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Alopecia Market
- 14.1. South Korea Alopecia Market Overview
- 14.2. South Korea Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Alopecia Market
- 15.1. Western Europe Alopecia Market Overview
- 15.2. Western Europe Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Alopecia Market
- 16.1. UK Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Alopecia Market
- 17.1. Germany Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Alopecia Market
- 18.1. France Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Alopecia Market
- 19.1. Italy Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Alopecia Market
- 20.1. Spain Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Alopecia Market
- 21.1. Eastern Europe Alopecia Market Overview
- 21.2. Eastern Europe Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Alopecia Market
- 22.1. Russia Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Alopecia Market
- 23.1. North America Alopecia Market Overview
- 23.2. North America Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Alopecia Market
- 24.1. USA Alopecia Market Overview
- 24.2. USA Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Alopecia Market
- 25.1. Canada Alopecia Market Overview
- 25.2. Canada Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Alopecia Market
- 26.1. South America Alopecia Market Overview
- 26.2. South America Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Alopecia Market
- 27.1. Brazil Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Alopecia Market
- 28.1. Middle East Alopecia Market Overview
- 28.2. Middle East Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Alopecia Market
- 29.1. Africa Alopecia Market Overview
- 29.2. Africa Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Alopecia Market Competitive Landscape And Company Profiles
- 30.1. Alopecia Market Competitive Landscape
- 30.2. Alopecia Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson and Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Alopecia Market Other Major And Innovative Companies
- 31.1. Sanofi SA
- 31.2. GlaxoSmithKline Plc
- 31.3. Eli Lilly and Company
- 31.4. Boehringer Ingelheim International GmbH
- 31.5. Allergan Plc
- 31.6. Teva Pharmaceutical Industries Ltd.
- 31.7. Mylan N.V.
- 31.8. Sun Pharmaceutical Industries Ltd.
- 31.9. Perrigo Company Plc
- 31.10. Intertek Group Plc
- 31.11. Dr. Reddy's Laboratories Ltd.
- 31.12. Cipla Limited
- 31.13. Almirall S.A.
- 31.14. Aclaris Therapeutics Inc.
- 31.15. Curallux LLC
32. Global Alopecia Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Alopecia Market
34. Recent Developments In The Alopecia Market
35. Alopecia Market High Potential Countries, Segments and Strategies
- 35.1 Alopecia Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Alopecia Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Alopecia Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
